Abstract
Social phobia is emerging as an important cause of psychiatric morbidity. Reasons for this are described, as are clinical issues of importance to social phobia, including the extensive associated distress and disability. The use of phenelzine, atenolol, buspirone, fluoxetine, and moclobemide are described. Diagnostic and transcultural aspects of social phobia are described.
MeSH terms
-
Adolescent
-
Atenolol / therapeutic use
-
Benzamides / therapeutic use
-
Buspirone / therapeutic use
-
Child
-
Clinical Trials as Topic
-
Female
-
Fluoxetine / therapeutic use
-
Humans
-
Male
-
Moclobemide
-
Phenelzine / therapeutic use
-
Phobic Disorders / diagnosis
-
Phobic Disorders / drug therapy*
-
Phobic Disorders / psychology
-
Placebos
Substances
-
Benzamides
-
Placebos
-
Fluoxetine
-
Atenolol
-
Phenelzine
-
Moclobemide
-
Buspirone